@xconomy.com 1 month ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com 5 months ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com 9 months ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com 9 months ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com 10 months ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com 10 months ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com 10 months ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com 11 months ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com 11 months ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 1 year ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com 1 year ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com 1 year ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com 1 year ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com 1 year ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com 1 year ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com 1 year ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com 1 year ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@engadget.com 1 year ago
GSK to use 23andMe’s DNA library in drug development
@techcrunch.com 3 years ago
GlaxoSmithKline and Google’s life science wing form new bioelectronic medicine company
@theverge.com 3 years ago
GlaxoSmithKline and Google team up to create new bioelectronics health company
@techcrunch.com 3 years ago
GlaxoSmithKline taps Apple’s ResearchKit for an arthritis study
@theverge.com 3 years ago
Apple partners with pharmaceutical giant GlaxoSmithKline for first clinical study
@extremetech.com 4 years ago
Drug company reneges on promise to reverse 5,400-percent price hike on Daraprim